Kun Cheng View Appointment Options Kun Cheng Appointment Options Research & Selected Publications Share Copy Link Email Link Print Page Facebook X Instagram LinkedIn Back Gmail Outlook Apple Mail Yahoo! Mail Appointment Options Whether you’re seeking a new patient appointment or exploring treatment options and looking for a second opinion, our Siteman care coordinators are ready to assist you. Request an Appointment Call Us Refer a Patient Research & Selected Publications Silencing CD24 Inhibits Proliferation, Migration, and Chemoresistance in Triple-Negative Breast Cancer Cells Silencing CD24 Inhibits Proliferation, Migration, and Chemoresistance in Triple-Negative Breast Cancer Cells Authors: Liu Y, Guo Y, Lin CY, [...]one or more additional authors omitted Cheng K Journal & Year: Pharm Res | 2026 An Emulsion-Based Microneedle Formulation for Transdermal Delivery of Peptide Therapeutics An Emulsion-Based Microneedle Formulation for Transdermal Delivery of Peptide Therapeutics Authors: Hasan R, Guo Y, Zhao Z, [...]one or more additional authors omitted Cheng K Journal & Year: ACS Biomater Sci Eng | 2026 Lipid and polymeric nanocarriers for siRNA delivery to the brain Lipid and polymeric nanocarriers for siRNA delivery to the brain Authors: Koirala S, Cheng K Journal & Year: J Control Release | 2025 Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis Small extracellular vesicles (sEVs) in pancreatic cancer progression and diagnosis Authors: Hasan R, Zhao Z, Li Y, [...]one or more additional authors omitted Cheng K Journal & Year: J Control Release | 2025 Development of a peptide-based tumor-activated checkpoint inhibitor for cancer immunotherapy Development of a peptide-based tumor-activated checkpoint inhibitor for cancer immunotherapy Authors: Zhao Z, Fetse J, Mamani UF, [...]one or more additional authors omitted Cheng K Journal & Year: Acta Biomater | 2025 Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy Exploring Multivalency in the Development of Anti-PD-L1 Peptides for Cancer Immunotherapy Authors: Mamani UF, Ibrahim MN, Liu Y, [...]one or more additional authors omitted Cheng K Journal & Year: Pharm Res | 2024 Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth Delivery of a STING Agonist Using Lipid Nanoparticles Inhibits Pancreatic Cancer Growth Authors: Shaji SG, Patel P, Mamani UF, [...]one or more additional authors omitted Cheng K Journal & Year: Int J Nanomedicine | 2024 A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistance Authors: Zhou J, Lyu N, Wang Q, [...]one or more additional authors omitted Cheng K, [...]one or more additional authors omitted Li G Journal & Year: Cancer Lett | 2023
